Sign In
Buy IONS
$73.82
+0.85 (+1.16%)
At Close: Jun 03, 2026
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
12:25pm, Monday, 10'th Aug 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Roche Holding
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Evofem Biosciences (EVFM
Ionis Pharmaceuticals (IONS) Gets a Hold Rating from Cowen & Co. - Markets
04:03pm, Sunday, 09'th Aug 2020
In a report issued on August 5, Yaron Werber from Cowen & Co. maintained a Hold rating on Ionis Pharmaceuticals
Ionis (IONS) Q2 Loss Narrower Than Expected, Revenues Miss
01:21pm, Thursday, 06'th Aug 2020
Ionis (IONS) posts narrower-than-expected Q2 loss. Sales miss estimates.
Ionis Pharmaceuticals (IONS) Receives a Hold from William Blair - Markets
06:30pm, Wednesday, 05'th Aug 2020
William Blair analyst Myles Minter reiterated a Hold rating on Ionis Pharmaceuticals (IONS – Research Report) today. The company’s shares
Ionis Pharmaceuticals (IONS) Receives a Buy from Needham - Markets
06:06pm, Wednesday, 05'th Aug 2020
Needham analyst Chad Messer assigned a Buy rating to Ionis Pharmaceuticals (IONS – Research Report) today and set a price
Ionis Pharmaceuticals (IONS) Reports Q2 Loss, Misses Revenue Estimates
12:55pm, Wednesday, 05'th Aug 2020
Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 17.86% and -3.17%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Ionis Pharmaceuticals: Q2 Earnings Insights
11:47am, Wednesday, 05'th Aug 2020
Shares of Ionis Pharmaceuticals (NASDAQ:IONS) remained unaffected after the company reported Q2 results.Quarterly Results Earnings per share fell 2200.00% year over year to ($0.23), which beat the est
Ionis reports second quarter 2020 financial results and recent business achievements
11:00am, Wednesday, 05'th Aug 2020
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported its financial results for the second quarter of 2020 and recent business highlights.
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
Ionis Pharmaceuticals Inc (NASDAQ:IONS) Stock Position Lifted by Nissay Asset Management Corp Japan ADV
07:38am, Monday, 03'rd Aug 2020
Nissay Asset Management Corp Japan ADV grew its position in Ionis Pharmaceuticals Inc (NASDAQ:IONS) by 11.9% in the second quarter, according to its most recent 13F filing with the Securities and Exch
Assenagon Asset Management S.A. Invests $221,000 in Ionis Pharmaceuticals Inc (NASDAQ:IONS)
10:08am, Sunday, 02'nd Aug 2020
Assenagon Asset Management S.A. bought a new position in Ionis Pharmaceuticals Inc (NASDAQ:IONS) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exch
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
10 Biggest Biotechnology Companies
11:32pm, Thursday, 30'th Jul 2020
With Novo Nordisk at the top of the list, these are the 10 biggest biotechnology companies by 12-month trailing revenue.
